Migration of a pancreatic duct stent into the peritoneal cavity during chemotherapy for pancreatic malignant lymphoma

Taki, Shinya; Maekita, Takao; Shimizu, Ryo; Yamashita, Yasunobu; Iguchi, Mikitaka; Kitano, Masayuki

doi:10.1007/s12328-021-01477-5

Cited by 4 publications

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, cases of intestinal wall damage caused by stents have been reported. 90,91 Duodenoscopy or colonoscopy can be used to remove these incarcerated stents. 91,92 Contrarily, proximal stent migration further into the pancreatic duct presents a more serious condition and can result in pancreatitis, pancreatic parenchymal damage, or splenic artery perforation.…”

Section: Stent Dysfunctionmentioning

confidence: 99%

“…Because the stent can be naturally excreted through the intestine after passing through the duodenum, distally displaced stents are rarely harmful. However, cases of intestinal wall damage caused by stents have been reported 90,91 . Duodenoscopy or colonoscopy can be used to remove these incarcerated stents 91,92 .…”

Section: Complications Of Endoscopic Stent Placementmentioning

confidence: 99%

See 1 more Smart Citation

Pancreatic duct stents

Yi¹,

Li²,

Hu³

2022

J of Digest Diseases

View full text Add to dashboard Cite

Pancreatic duct stenting using endoscopy or surgery is widely used for the management of benign and malignant pancreatic diseases. Endoscopic pancreatic stents are mainly used to relieve pain caused by chronic pancreatitis and pancreas divisum, and to treat pancreatic duct disruption and stenotic pancreaticointestinal anastomosis after surgery. They are also used to prevent postendoscopic retrograde cholangiopancreatography pancreatitis and postoperative pancreatic fistula, treat pancreatic cancer, and locate radiolucent stones. Recent advances in endoscopic techniques, such as endoscopic ultrasonography and balloon enteroscopy, and newly designed stents have broadened the indications for pancreatic duct stenting. In this review we outlined the types, insertion procedures, efficacy, and complications of endoscopic pancreatic duct stent placement, and summarized the applications of pancreatic duct stents in surgery.

show abstract

Section: Stent Dysfunctionmentioning

confidence: 99%

Section: Complications Of Endoscopic Stent Placementmentioning

confidence: 99%

Pancreatic duct stents

Yi¹,

Li²,

Hu³

2022

J of Digest Diseases

View full text Add to dashboard Cite

show abstract

Antineoplastics/immunosuppressants/non-opioid-analgesics

2022

Reactions Weekly

View full text Add to dashboard Cite

Endotherapy for the Proximal Migration of Pancreatic Stents

Cai,

Wang,

et al. 2024

Pancreas

View full text Add to dashboard Cite

Objectives Proximal migration is one of the complications after pancreatic duct stenting. This study aimed to determine the incidence of proximal migration and to analyze the rescue methods. Methods A search was performed in MEDLINE/EMBASE database. The literatures included were reviewed and analyzed. Retrieval tools were classified into 3 classes: Class A works by indirectly contacting the outer surface of the stent. Class B works by directly contacting the outer surface. Class C works by directly contacting the inner surface. Results 416 literatures were retrieved from 1983 to 2021. 15 literatures were included. The incidence of proximal migration of pancreatic stents was 4.7% (106/2246). The success rate of endotherapy was 86.6% (214/247), and the surgical conversion rate of it was 9.3%. Among the 214 cases in which the displaced stents were successfully removed under endoscopy, 49 cases (22.9%) used Class A methods, 154 cases (72.0%) used Class B methods and 11 cases (5.1%) used Class C methods. The overall rate of postoperative complication was 12.1%, including postprocedure pancreatitis (9.1%, 18/247), followed by bleeding (1.5%), perforation (1.0%) and biliary infection (0.5%). Conclusions Endoscopy is an effective method for the treatment of proximal displacement of pancreatic stents with acceptable complication rate.

show abstract

Migration of a pancreatic duct stent into the peritoneal cavity during chemotherapy for pancreatic malignant lymphoma

Cited by 4 publications

References 6 publications

Pancreatic duct stents

Pancreatic duct stents

Antineoplastics/immunosuppressants/non-opioid-analgesics

Endotherapy for the Proximal Migration of Pancreatic Stents

Contact Info

Product

Resources

About